Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Achilles Therapeutics Plc (ACHL)

Achilles Therapeutics Plc (ACHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Achilles Therapeutics plc Announces Transfer of ADS Listing to Nasdaq Capital Market Quiver Quantitative, Inc. - Tue Nov 19, 2024

Achilles Therapeutics' ADSs will transfer to Nasdaq Capital Market, extending compliance period for minimum bid price requirement.Quiver AI SummaryAchilles Therapeutics plc announced the approval from...

ACHL : 1.4800 (+0.68%)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation Investor Brand Network - Thu Sep 21, 2023

NetworkNewsWire Editorial Coverage : More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation...

JAZZ : 253.87 (-0.39%)
ACHL : 1.4800 (+0.68%)
RHHBY : 54.7000 (+1.45%)
ALXO : 2.03 (+0.50%)
GNPX : 7.81 (+4.27%)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation Investor Brand Network - Wed Sep 20, 2023

NetworkNewsWire Editorial Coverage : More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation...

JAZZ : 253.87 (-0.39%)
ACHL : 1.4800 (+0.68%)
RHHBY : 54.7000 (+1.45%)
ALXO : 2.03 (+0.50%)
GNPX : 7.81 (+4.27%)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation FinancialNewsMedia - Wed Sep 20, 2023

EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END

JAZZ : 253.87 (-0.39%)
ACHL : 1.4800 (+0.68%)
RHHBY : 54.7000 (+1.45%)
ALXO : 2.03 (+0.50%)
GNPX : 7.81 (+4.27%)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation PR Newswire - Wed Sep 20, 2023

/PRNewswire/ -- More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the...

JAZZ : 253.87 (-0.39%)
ACHL : 1.4800 (+0.68%)
RHHBY : 54.7000 (+1.45%)
ALXO : 2.03 (+0.50%)
GNPX : 7.81 (+4.27%)
Achilles Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights Globe Newswire - Tue Aug 9, 2022

- Additional clinical data from the ongoing Phase I/IIa trials in advanced NSCLC (CHIRON) and melanoma (THETIS) expected to be available in Q4 2022 - -...

ACHL : 1.4800 (+0.68%)
Secarna Pharmaceuticals and Achilles Therapeutics Sign Research, Option and License Agreement to Develop Optimized T Cell Therapies ACCESS Newswire - Wed Nov 10, 2021

- Secarna's LNAplusTM ASOs have the potential to optimize personalized T cell therapies being developed by Achilles - Secarna's industry-leading antisense oligonucleotide (ASO) platform LNAplusTM enables...

ACHL : 1.4800 (+0.68%)

Barchart Exclusives

Texas Instruments vs. Qualcomm: One Pays Out 94% of Earnings. The Better Dividend Chip Stock Is Clear. Barchart - Fri Jul 24, 6:00PM CDT
Texas Instruments and Qualcomm offer different paths to AI growth and dividend income, but which chip stock gives investors the better setup? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.